ClinicalTrials.gg
RecruitingNCT06530134AUTOCAM-AVCUpdated Jul 31, 2024

Promote Awareness of the Driving Abilities of Post-stroke Patients.

An interventional study of Driving situation and video feedback and Driving situation and usual recommendations (without video feedback) in Cerebrovascular Accident, sponsored by Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape. Recruiting at 1 site in France. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2024-07-31.

Sponsored by Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Oct 2024, 2 years 1 month ago, but the record still lists the study as recruiting.
  • Started Oct 2021; still recruiting 5 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

Patients with cerebrovascular accident (CVA) may present with a deficit of awareness of the disorders which results in a lack of correct self-estimation of their own abilities and difficulties in terms of both cognition and driving. It is therefore important to develop tools to help professionals take this deficit into account in their driving assessments and also to help patients better identify their real abilities.

This research project thus proposes a protocol making it possible to promote decision-making whether or not to resume driving by multidisciplinary teams.

The main objective is to determine to what extent video feedback promotes awareness of the ability to manage post-stroke patients, compared to a group of control patients receiving the usual recommendations.

02

Conditions studied

  • Cerebrovascular Accident

Browse trials for

Keywords

  • post-stroke
03

In context

Stroke

8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.

This study's planned enrollment of 70 is above the median of 49 across 6,024 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape is the lead sponsor of 10 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Stroke (ischemic and / or hemorrhagic) between 1 month and 6 months
  • Holder of a driving license for more than 3 years
  • No resumption of driving
  • score ≥ 10
  • Affiliation to a social security scheme or beneficiary of such a scheme
  • Having signed a free, informed and written consent
  • Medically stable

Exclusion criteria

Exclusion Criteria:

  • Aphasia with severe comprehension disturbances, severe hemineglect, unstable epilepsy, severe visual disturbances (binocular vision \<6/10, visual field \<120 ° in binocular, \<50 ° to the right and to the left beyond the central point, \<30 ° vertically.
  • History of neurological disease responsible for cognitive impairment
  • Need for vehicle modifications except automatic gearbox
  • Subject being in a period of exclusion from another protocol
  • Insufficient command of the French language
  • Protected adults (curators)
  • Pregnancy declared
  • Being unable to issue their consent
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    With video feedback

    Activation of on-board cameras during driving situation.

    Other: Driving situation and video feedback

  • Other
    Without video feedback

    Non-Activation of on-board cameras during driving situation.

    Other: Driving situation and usual recommendations (without video feedback)

Interventions

  • OtherDriving situation and video feedback

    At the end of the driving situation, 35 patients will be asked to express themselves and analyze 4 driving situations resulting from the course of the driving situation using video feedback.

  • OtherDriving situation and usual recommendations (without video feedback)

    At the end of the driving situation, 35 patients will be asked to express themselves and analyze 4 driving situations resulting from the course of the driving situation without video feedback, according to the usual recommendations. Comparison of responses to all questionnaires and interview grids sent before and after driving, to patients and professionals will determine whether video feedback promotes awareness of the difficulties of driving post-stroke patients.

06

What researchers measure

Primary outcomes

  1. Awareness of driving behavior.

    This criterion will be measured using the difference between patient's and the professional's scores from the interview with the situation analyzes. If the difference between the patient's score and that of the professionals is close to zero, it means that the patient correctly self-estimates their driving abilities. If the difference is positive, it means the patient overestimates their abilities. If the difference is negative, it means the patient underestimates their abilities. The professionals score is the mean of the score of each professional (occupational therapist and driving instructor) The patient fills out the questionnaire before and after the interview. The two professionals fill out the questionnaire once, before the interview. This score of driving behavior awareness after the interview will be compared to that before the interview, reflecting any potiential change in awareness following the interview.

    Time frame: Day 0

Secondary outcomes

  1. The concordance between the opinion of the two professionals (driving instructor and occupational therapist) and that of the patient about returning to driving, then compare this concordance between the two arms.

    The score of question 4 of the "Q final-pro" questionnaire will be compared to question 7 of the "Q final-pa" questionnaire (with or without feedback depending on the arm). The differences between the two opinions (Patient Opinions-Professional Opinions) on all the evaluations will allow to establish a score "of concordance of the opinions of rework". A score equal to zero means that the opinions are the same between the patient and the professionals (best outcome), a positive or negative score means that the opinions are divergent. The closer the score is to zero, the better the result. The same process will be followed with the control group that did not receive video feedback in order to compare the concordance scores of the rework notices between the two arms.

    Time frame: Day 0

  2. The concordance between the opinion of the driving teacher and the occupational therapist after the on-road test

    Study of the concordance between the total score of the TRIP (Test Ride for Investigating Practical Fitness to Drive) grid (Qpost-cond-trip) of the driving teacher and that of the occupational therapist (score/100) Calcul of a correlation coefficient : the higher the coefficient, the more consistent the assessments between the 2 professionals are (better outcome).

    Time frame: Day 0

  3. The concordance between the opinion of the driving teacher and the occupational therapist for the interview grid

    Study of the concordance between the total score of the interview grid (Qentr-pro) of the driving teacher and that of the occupational therapist (score/28). Calcul of a correlation coefficient : the higher the coefficient, the more consistent the assessments between the 2 professionals are (better outcome).

    Time frame: Day 0

  4. Compare the MOCA score between patients who had a favorable opinion (PFO) and patients who had an unfavorable opinion (PUO)

    • \[MOCA test /30 score\] PFO compared to PUO (MOCA : Montreal Cognitive Assessment)

    Time frame: Day 0

  5. Compare the score of Rey's Figure between patients who had a favorable opinion (PFO) and patients who had an unfavorable opinion (PUO)

    • \[Rey's Figure score /36, execution time (s)\] PFO compared to PUO

    Time frame: Day 0

  6. Compare the score of Bell Test between patients who had a favorable opinion (PFO) and patients who had an unfavorable opinion (PUO)

    • \[Bell Test score /35, execution time (s)\] PFO compared to PUO

    Time frame: Day 0

  7. Compare the attentional performance between patients who had a favorable opinion (PFO) and patients who had an unfavorable opinion (PUO)

    TAP Scores PFO compared to PUO (TAP : Attention Assessment Tests)

    Time frame: Day 0

  8. Compare the information processing speed between patients who had a favorable opinion (PFO) and patients who had an unfavorable opinion (PUO)

    • Score combining the scores at the code and symbol tests /38 \] PFO compared to PUO (WAIS : Wechsler Adult Intelligence Scale)

    Time frame: Day 0

  9. Compare the working memory performance between patients who had a favorable opinion (PFO) and patients who had an unfavorable opinion (PUO)

    • \[WAIS-IV digit memory score /19\] PFO compared to PUO

    Time frame: Day 0

  10. Links between cognitive performance and the awareness score of driving skills.

    To study the links between cognitive performance and awareness, MOCA score will be correlated with awareness scores (Patient Score Difference - Professional Score obtained before the interview (Qentr-pro completed before the interview)).

    Time frame: Day 0

  11. Links between awareness of cognitive impairment and awareness of driving skills.

    To assess awareness of cognitive disorders, the difference in scores (Patient Score / Self-assessment - Professional Score / Hetero-assessment) of the BRIEF A will be calculated. The Brief A test (Behavior Rating Inventory of Executive Function) aims to investigate the existence of a deficit of consciousness of cognitive disorders in patients. The patient's assessment score from the self-assessment questionnaire will be compared with that of professionals (hetero-assessment). The difference between the two scores (Patient Score / Self-assessment - Average Professional Score / Hetero-assessment) will determine whether the patient has a lack of awareness of his cognitive disorders. If the difference (Patient Score - Professional Score) is positive, the patient overestimates his disorders; if it is negative, the patient underestimates them; if it is zero it means that the patient is estimating them correctly.

    Time frame: Day 0

  12. Become patients at 6 months

    The behaviors and driving strategies of patients 6 months after their resumption of driving (Q follow-up) will be compared with those declared in the initial questionnaire on the answers to the following questions: "Since you have resumed driving, do you think that you have more difficulty driving than before? "," If so, in which situations do you think you have more difficulty "," Since your recovery, do you think you are avoiding more situations than before? "," If so, what are the situations you think you can avoid the most? "," Since your recovery, have you developed different driving strategies for driving? "," If so, what strategies have you put in place to drive safely "," Since your recovery, has the activity of driving scared you more than before? "," Do you think the activity of driving is more tiring than before? "

    Time frame: At 6 months

  13. Acceptability of the video device by professionals and patients

    The acceptability of the video device by professionals will be measured by the answers obtained to question 6 of the final questionnaire completed by professionals (Qfinal-pro) (e.g. questions: as a professional, having video feedback was easy to use during the interview, choice of items to tick). The closer the score is to 12, the higher the acceptability of the video device by professionals. The acceptability of the video device by the patients will be measured thanks to the feelings that the patients will have expressed in question 2 of the final questionnaire (on interest, pleasure, stress, perceived usefulness, satisfaction and pleasure experienced by compared to the device).

    Time frame: Day 0

07

Study locations

1 of 1 sites recruiting
  • CMRRF de Kerpape
    Ploemeur, Bretagne 56270, France
    Recruiting
    • Marie-Caroline de Kerpape, CRA · Contactkerpape.arc@vyv3.fr · 0297826293
    • Pauline Coignard, Doctor · Principal investigator
    • Jean-Luc Le Guiet, Doctor · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2021 (actual). Primary completion is estimated for Oct 2024, 36 months after the start.

Of 3,108 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 36 months is above that.

Counting every sponsor, half of 3,252 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 20, 2021
First posted
Jul 31, 2024
StartActual
Oct 12, 2021
Primary completionEst.
Oct 2024
CompletionEst.
Nov 2024
Last update
Jul 31, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 31, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06530134
Lead sponsor
Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape
Collaborators
University Gustave Eiffel
Responsible party
Sponsor
First posted
Jul 31, 2024
Start date
Oct 12, 2021
Primary completion
Oct 2024 (estimated)
Completion
Nov 2024 (estimated)
Last update
Jul 31, 2024

Study contacts

Pauline Coignard, Doctor
Contact
pauline.coignard@vyv3.fr
0297826179 ext. +33
Marie-Caroline Delebecque, CRA
Contact
kerpape.arc@vyv3.fr
0297826293 ext. +33
Pauline Coignard, Doctor
principal investigator · CMRRF de Kerpape

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion